FTXH vs. CNCR ETF Comparison

Comparison of First Trust Nasdaq Pharmaceuticals ETF (FTXH) to Loncar Cancer Immunotherapy ETF (CNCR)
FTXH

First Trust Nasdaq Pharmaceuticals ETF

FTXH Description

The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.

Grade (RS Rating)

Last Trade

$28.01

Average Daily Volume

6,658

Number of Holdings *

48

* may have additional holdings in another (foreign) market
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$16.62

Average Daily Volume

39,506

Number of Holdings *

73

* may have additional holdings in another (foreign) market
Performance
Period FTXH CNCR
30 Days -0.93% -6.26%
60 Days 3.30% 18.80%
90 Days 5.49% 23.39%
12 Months 10.42% 36.45%
11 Overlapping Holdings
Symbol Grade Weight in FTXH Weight in CNCR Overlap
ACLX C 0.67% 1.98% 0.67%
ARVN D 0.48% 1.62% 0.48%
BMY D 7.31% 0.79% 0.79%
BPMC C 0.47% 1.62% 0.47%
EXEL B 0.92% 1.0% 0.92%
IDYA D 0.5% 1.42% 0.5%
KYMR C 0.47% 1.95% 0.47%
MRK B 6.96% 1.05% 1.05%
MRUS C 0.47% 1.75% 0.47%
NUVL D 0.47% 1.53% 0.47%
REGN C 3.58% 1.07% 1.07%
FTXH Overweight 37 Positions Relative to CNCR
Symbol Grade Weight
PFE D 7.45%
ABBV A 7.16%
JNJ D 6.9%
LLY B 3.67%
GILD F 3.67%
BIIB F 3.59%
CAH B 3.57%
AMGN D 3.56%
VRTX D 3.5%
VTRS D 3.43%
UTHR C 3.4%
JAZZ F 3.29%
ZTS F 3.08%
OGN C 2.57%
CRL B 2.25%
PRGO C 1.43%
MEDP B 1.43%
HALO C 1.25%
ALKS F 1.04%
INCY F 1.0%
NBIX C 0.87%
PBH C 0.83%
ELAN B 0.8%
ILMN F 0.64%
KRYS C 0.54%
EXAS D 0.54%
BMRN F 0.49%
SRPT C 0.49%
ITCI D 0.48%
IONS F 0.47%
RYTM D 0.46%
VKTX C 0.46%
TGTX F 0.45%
RARE D 0.45%
BEAM C 0.44%
CRSP D 0.43%
ACAD F 0.4%
FTXH Underweight 62 Positions Relative to CNCR
Symbol Grade Weight
JANX D -3.67%
YMAB C -3.09%
MRSN D -3.08%
FATE C -3.07%
MGNX D -3.0%
IOVA C -2.65%
RVMD C -2.37%
MOR B -2.04%
AUTL C -1.98%
KURA C -1.96%
SWTX C -1.78%
SMMT D -1.73%
NUVB C -1.57%
INBX D -1.52%
CGEM D -1.49%
PRLD C -1.38%
GERN C -1.37%
NRIX C -1.34%
IGMS F -1.26%
SNDX C -1.2%
GLUE C -1.15%
BCYC C -1.13%
RXRX F -1.13%
TSVT D -1.12%
LYEL D -1.1%
ACET D -1.09%
NGM C -1.08%
IMCR D -1.07%
KPTI C -1.07%
HCM C -1.07%
DCPH D -1.05%
TYRA D -1.03%
BMEA F -1.02%
ELVN C -1.02%
ALLO D -1.02%
XNCR C -1.0%
DAWN D -0.98%
PGEN D -0.93%
FHTX C -0.92%
IMTX F -0.85%
ITOS C -0.84%
AURA F -0.83%
CRBU F -0.82%
STRO D -0.81%
LEGN F -0.8%
RLAY F -0.78%
VOR D -0.77%
SDGR F -0.76%
ERAS D -0.76%
RCUS C -0.76%
IPHA D -0.75%
BNTX F -0.74%
GMAB D -0.71%
ACRV D -0.55%
DNA F -0.54%
ZNTL D -0.53%
RPTX F -0.46%
REPL D -0.42%
RAPT F -0.4%
AGEN F -0.39%
IMRX F -0.31%
GNLX F -0.24%
Compare ETFs